PRESS RELEASE published on 01/01/2023 at 00:30, 3 years 5 months ago Ivrnet Inc. Announces Amendment to Term Loan and Credit Facility
PRESS RELEASE published on 10/31/2022 at 18:23, 3 years 7 months ago Paulic Meunerie : annule et remplace : Rapport financier semestriel 2022
PRESS RELEASE published on 11/24/2020 at 14:30, 5 years 7 months ago PJSC Magnit notifies on the transactions by persons discharging managerial responsibilities and persons clearly associated with them (PDMR/PCA)
PRESS RELEASE published on 11/24/2020 at 13:00, 5 years 7 months ago Royal KPN N.V. Press Release: Members of Board of Management buy KPN shares
Published on 06/26/2026 at 14:05, 2 hours 52 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 2 hours 57 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 3 hours 57 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 4 hours 12 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:30, 1 hour 26 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 1 hour 33 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 15:23, 1 hour 34 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/26/2026 at 15:22, 1 hour 35 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 06/26/2026 at 07:00, 9 hours 57 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 9 hours 57 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel